$2.82 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$17.1 MillionTotal revenue in the last quarter.
$-23.1 MillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
$-0.28Earnings per share is the amount of net income that is attributed to each single share outstanding.
-Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-53.06xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$-23.5 MillionEarnings before interest expenses and taxes in the last quarter.
404The number of full time employees.
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M. TheSeeking Alpha, 13 days ago
Pacific Biosciences of California (NASDAQ:PACB) shares shot up 5.2% during mid-day trading on Thursday . The stock traded as high as $13.86 and last traded at $13.77. 2,846,571 shares were traded d...The Olympia Report, about 1 month ago
Analysts forecast that Pacific Biosciences of California (NASDAQ:PACB) will announce $20.40 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have i...Daily Political, about 1 month ago